tazarotene has been researched along with Hypermelanosis in 9 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with facial mottled hyperpigmentation of at least moderate severity and an overall integrated assessment of photodamage score of at least moderate applied tazarotene 0." | 5.12 | Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study. ( Draelos, Z; Horwitz, S; Lowe, N; Menter, A; Tanghetti, E, 2006) |
| " All significant between-group differences in efficacy measures were in favor of tazarotene - for fine wrinkling at the study endpoint and, at earlier timepoints, for treatment success (> or =50% global improvement), and the overall integrated assessment of photodamage, mottled hyperpigmentation, and coarse wrinkling." | 5.11 | Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. ( Gifford, M; Goldman, M; Kang, S; Lowe, N; Poulin, Y; Rosenzweig, H; Tanghetti, E; Tse, Y; Yamauchi, P, 2004) |
| "In this multicentre, double-blind, randomized, vehicle-controlled study, 50 patients with photodamaged facial skin (at least mild fine wrinkling and mottled hyperpigmentation, with at least one of these being moderate) were randomized to apply tazarotene 0." | 5.11 | Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin. ( Holland, JM; Kaidbey, K; Lim, J; Loven, KH; Machtinger, LA; Parizadeh, DD; Rist, TE; Sefton, J; Walker, PS; Wilson, DC, 2004) |
| "A total of 568 patients with at least moderate fine wrinkling or mottled hyperpigmentation applied tazarotene 0." | 5.11 | A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. ( Gibson, JR; Kang, S; Krueger, GG; Lew-Kaya, D; Sefton, J; Tanghetti, EA; Walker, PS, 2005) |
| "Tazarotene cream and tretinoin cream significantly improved mottled hyperpigmentation and fine wrinkles." | 5.09 | Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily f ( Bhawan, J; Gibson, JR; Kang, S; Lew-Kaya, DA; Leyden, JJ; Lowe, NJ; Matsumoto, RM; Ortonne, JP; Phillips, TJ; Sefton, J; Walker, PS; Weinstein, GD, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gleghorn, K | 1 |
| Riddle, T | 1 |
| Subrt, A | 1 |
| Kelly, E | 1 |
| Tanghetti, E | 3 |
| Dhawan, S | 1 |
| Green, L | 1 |
| Del Rosso, J | 1 |
| Draelos, Z | 2 |
| Leyden, J | 1 |
| Shalita, A | 1 |
| Glaser, DA | 1 |
| Grimes, P | 2 |
| Webster, G | 1 |
| Barnett, P | 1 |
| Le Gall, N | 1 |
| Lowe, N | 2 |
| Gifford, M | 1 |
| Poulin, Y | 1 |
| Goldman, M | 1 |
| Tse, Y | 1 |
| Yamauchi, P | 1 |
| Rosenzweig, H | 1 |
| Kang, S | 3 |
| Machtinger, LA | 1 |
| Kaidbey, K | 1 |
| Lim, J | 1 |
| Loven, KH | 1 |
| Rist, TE | 1 |
| Wilson, DC | 1 |
| Parizadeh, DD | 1 |
| Sefton, J | 3 |
| Holland, JM | 1 |
| Walker, PS | 3 |
| Krueger, GG | 1 |
| Tanghetti, EA | 1 |
| Lew-Kaya, D | 1 |
| Gibson, JR | 2 |
| Callender, V | 1 |
| Horwitz, S | 1 |
| Menter, A | 1 |
| Saks, K | 1 |
| Levitt, JO | 1 |
| Leyden, JJ | 1 |
| Lowe, NJ | 1 |
| Ortonne, JP | 1 |
| Phillips, TJ | 1 |
| Weinstein, GD | 1 |
| Bhawan, J | 1 |
| Lew-Kaya, DA | 1 |
| Matsumoto, RM | 1 |
7 trials available for tazarotene and Hypermelanosis
| Article | Year |
|---|---|
Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Dermatologic Agents; | 2010 |
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Topics: Administration, Topical; Dermatologic Agents; Double-Blind Method; Emollients; Face; Female; Humans; | 2004 |
Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
Topics: Adult; Aged; Double-Blind Method; Facial Dermatoses; Female; Humans; Hyperpigmentation; Keratinocyte | 2004 |
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Double-Blind Method; Facial Dermatoses; Female; | 2005 |
Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Child; Dermato | 2006 |
Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
Topics: Administration, Topical; Chi-Square Distribution; Dermatologic Agents; Double-Blind Method; Female; | 2006 |
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily f
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blin | 2001 |
2 other studies available for tazarotene and Hypermelanosis
| Article | Year |
|---|---|
Postinflammatory hyperpigmentation following treatment of hyperkeratosis lenticularis perstans with tazarotene cream 0.1.
Topics: Dermatologic Agents; Female; Humans; Hyperpigmentation; Keratosis; Middle Aged; Nicotinic Acids | 2019 |
Tazarotene 0.1 percent cream fares better than erbium:YAG laser or incision and drainage in a patient with eruptive vellus hair cysts.
Topics: Child; Cysts; Dermatologic Agents; Drug Evaluation; Female; Hair Follicle; Humans; Hyperpigmentation | 2006 |